CCND1 and melanoma: Therefore, these results show that constitutive MAPK reactivation, p53/p21 expression and cyclin D1/pRb downregulation could trigger senescence in V600EBRAF mutant melanoma cells with acquired resistance after washing out vemurafenib, and that continuous exposure to the drug may be associated with such resistance.